Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY | 17-AAG |
FIMM | Tanespimycin |
CTRPv2 | tanespimycin |
PharmacoGx | 17-AAG |
Database | Identifier |
---|---|
Smiles: | CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC |
Inchikey: | AYUNIORJHRXIBJ-TXHRRWQRSA-N |
Pubchem: | 6505803 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UPP1 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
mRNA | CBLN1 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-09 |
mRNA | GNAO1 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-09 |
mRNA | CTDSP1 | CCLE | pan-cancer | AAC | 0.27 | 2e-09 |
mRNA | DDX60L | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-09 |
mRNA | FGF14 | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-09 |
mRNA | CD109 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-09 |
mRNA | PPM1E | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-09 |
mRNA | EIF2AK4 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-09 |
mRNA | ENPP4 | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-09 |